ROSE TAYLOR-LEWIS: Open Payments
NPI 1538370911 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 31 payments from 11 companies in 2025. Trend: 2023 $1,405 · 2024 $1,431 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $398 |
| Amgen Inc. | 3 | $181 |
| Phathom Pharmaceuticals, Inc. | 1 | $113 |
| Dexcom, Inc. | 2 | $111 |
| Axsome Therapeutics, Inc. | 1 | $111 |
| Otsuka America Pharmaceutical, Inc. | 2 | $88 |
| AstraZeneca Pharmaceuticals LP | 1 | $51 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: CAPLYTA, OTEZLA, VOQUEZNA, Dexcom G6 Transmitter, Auvelity, REXULTI, BREZTRI, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
